Bone marrow-derived mesenchymal stem cells (MSCs) to enhance nerve regeneration and functional recovery in vascular composite allotransplantation (VCA)

MLA

Shashikumar K Salgar, et al. “Bone Marrow-Derived Mesenchymal Stem Cells (MSCs) to Enhance Nerve Regeneration and Functional Recovery in Vascular Composite Allotransplantation (VCA).” The Journal of Immunology, vol. 198, May 2017, p. 82.23. EBSCOhost, https://doi.org/10.4049/jimmunol.198.supp.82.23.

APA

Shashikumar K Salgar, Jason Bingham, Kevin Kniery, Nikolas Jorstad, Iren Horkayne-Szakaly, & Zachary Hoffer. (2017). Bone marrow-derived mesenchymal stem cells (MSCs) to enhance nerve regeneration and functional recovery in vascular composite allotransplantation (VCA). The Journal of Immunology, 198, 82.23. https://doi.org/10.4049/jimmunol.198.supp.82.23

Chicago

Shashikumar K Salgar, Jason Bingham, Kevin Kniery, Nikolas Jorstad, Iren Horkayne-Szakaly, and Zachary Hoffer. 2017. “Bone Marrow-Derived Mesenchymal Stem Cells (MSCs) to Enhance Nerve Regeneration and Functional Recovery in Vascular Composite Allotransplantation (VCA).” The Journal of Immunology 198 (May): 82.23. doi:10.4049/jimmunol.198.supp.82.23.